rdf:type |
|
lifeskim:mentions |
umls-concept:C0010031,
umls-concept:C0010648,
umls-concept:C0030705,
umls-concept:C0332237,
umls-concept:C0392756,
umls-concept:C0392760,
umls-concept:C0442844,
umls-concept:C0991568,
umls-concept:C1280500,
umls-concept:C1522168,
umls-concept:C2931187
|
pubmed:issue |
5
|
pubmed:dateCreated |
1991-1-8
|
pubmed:abstractText |
We studied the usefulness of topical cysteamine ophthalmic drops in reducing crystal formation within the corneas of patients affected by nephropathic cystinosis. A dosage of 0.3% cysteamine given four times daily was chosen as a more manageable method than a previously reported protocol of hourly administration of 0.11% drops. No reduction in crystal formation was observed in our patients; they were followed for seven months.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0191-3913
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
272-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2246744-Administration, Topical,
pubmed-meshheading:2246744-Adult,
pubmed-meshheading:2246744-Child,
pubmed-meshheading:2246744-Child, Preschool,
pubmed-meshheading:2246744-Cornea,
pubmed-meshheading:2246744-Corneal Diseases,
pubmed-meshheading:2246744-Crystallization,
pubmed-meshheading:2246744-Cysteamine,
pubmed-meshheading:2246744-Cystinosis,
pubmed-meshheading:2246744-Female,
pubmed-meshheading:2246744-Humans,
pubmed-meshheading:2246744-Kidney Diseases,
pubmed-meshheading:2246744-Male,
pubmed-meshheading:2246744-Prognosis,
pubmed-meshheading:2246744-Visual Acuity
|
pubmed:articleTitle |
The effect of topical cysteamine drops on reducing crystal formation within the cornea of patients affected by nephropathic cystinosis.
|
pubmed:affiliation |
Department of Biochemistry, University of Ottawa, Ontario, Canada.
|
pubmed:publicationType |
Journal Article
|